Optimizing antimicrobial drug dosing in critically ill patients
Funding Information: Conflicts of Interest: P.P. has received lecture fees and advisory board from MSD, Gilead, Pfizer; L.C. and P.M. declared no conflicts of interest related to the underlying topics; J.G.P. received unre‐ stricted research grants from Merck Sharp and Dohme; received lecture and ad...
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | review |
| Language: | eng |
| Published: |
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10362/121296 |
| Country: | Portugal |
| Oai: | oai:run.unl.pt:10362/121296 |